Cargando…
Antitumor activity of the combination of an HSP90 inhibitor and a PI3K/mTOR dual inhibitor against cholangiocarcinoma
The PI3K/Akt/mTOR pathway is overactivated and heat shock protein (HSP) 90 is overexpressed in common cancers. We hypothesized that targeting both pathways can kill intrahepatic cholangiocarcinoma (CCA) cells. HSP90 and PTEN protein expression was evaluated by immunohistochemical staining of samples...
Autores principales: | Chen, Ming-Huang, Chiang, Kun-Chun, Cheng, Chi-Tung, Huang, Shih-Chiang, Chen, Yeng-Yang, Chen, Tsung-Wen, Yeh, Ta-Sen, Jan, Yi-Yin, Wang, Hsi-Ming, Weng, Jiang-Jie, Chang, Peter Mu-Hsin, Liu, Chun-Yu, Li, Chung-Pin, Chao, Yee, Chen, Ming-Han, Huang, Chi-Ying F., Yeh, Chun-Nan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058012/ https://www.ncbi.nlm.nih.gov/pubmed/24796583 |
Ejemplares similares
-
mTOR Inhibitors in Advanced Biliary Tract Cancers
por: Wu, Chao-En, et al.
Publicado: (2019) -
Peritumoral SPARC expression and patient outcome with resectable intrahepatic cholangiocarcinoma
por: Cheng, Chi-Tung, et al.
Publicado: (2015) -
Efficacy of an HSP90 inhibitor, ganetespib, in preclinical thyroid cancer models
por: Lin, Shu-Fu, et al.
Publicado: (2017) -
Elevated expression of HSP90 and the antitumor effect of an HSP90 inhibitor via inactivation of the Akt/mTOR pathway in undifferentiated pleomorphic sarcoma
por: Bekki, Hirofumi, et al.
Publicado: (2015) -
Identification of SPHK1 as a therapeutic target and marker of poor prognosis in cholangiocarcinoma
por: Chen, Ming-Huang, et al.
Publicado: (2015)